Mariner Wealth Advisors »

Keros Therapeutics shares owned by Mariner Wealth Advisors

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Mariner Wealth Advisors from 13F filings

Historical chart of Mariner Wealth Advisors investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Mariner Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Mariner Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $310k 15k 20.36
2025-09-30 $249k 16k 15.82

More positions owned by Mariner Wealth Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Ishares Tr Core Us Aggbd Et (AGG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Mcp Etf (IJH)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Mariner Wealth Advisors

Top funds holding Keros Therapeutics

BlackRock
Vanguard Group
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
State Street Corporation
Alkeon Capital Management
Madison Avenue Partners
OrbiMed Advisors
Qube Research & Technologies
Jacobs Levy Equity Management
Federated Investors
Geode Capital Management
Nantahala Capital Management
Renaissance Technologies
Goldman Sachs Group

View all funds holding Keros Therapeutics